Skip to content

Clinical trials

Phase 1/2 Anemia, Sickle Cell trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Anemia, Sickle Cell Phase: Phase 1/2 Clear all

78 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20052
20062
20072
20084
20095
20114
20123
20135
20147
20152
20163
20173
20184
20193
20204
20213
20223
20233
20245
20252
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed28
Recruiting13
Terminated13
Active, not recruiting12
Unknown status4
Withdrawn4
Not yet recruiting3
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Heart, Lung, and Blood Institute (NHLBI)8
Assistance Publique - Hôpitaux de Paris3
Children's Hospital Los Angeles3
Children's Hospital Medical Center, Cincinnati3
Bellicum Pharmaceuticals2
Diane George2
Gamida Cell ltd2
Genetix Biotherapeutics Inc.2
Lagos State University2
Talaris Therapeutics Inc.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Anemia, Sickle Cell78
Hemoglobinopathies9
Thalassemia9
beta-Thalassemia8
Anemia, Diamond-Blackfan7
Anemia6
Anemia, Aplastic5
Bone Marrow Failure Disorders5
Genetic Diseases, Inborn5
Primary Immunodeficiency Diseases4

Trials

Showing 26 to 50 of 78. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.